ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Explore very high cash back cards that come with no annual fee. Maximize your earnings effortlessly.
26,557 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
When a daughter tried sell mother’s assets, a routine real estate conversation uncovered a troubling pattern of elder...
A corporate pilot pairs AI coaching with micro-workout drills to curb digital distraction, signaling potential gains ...
A robot rollout tied to Melania Trump ignites a national debate over funding and the future of public schools. The te...
NVIDIA’s Vera CPU will integrate SK Hynix memory, signaling closer collaboration between the chipmaker and the Korean...
In a rapid turn of events, Bayer rode a Supreme Court win on Roundup lawsuits, then pressed for glyphosate tariffs. F...
What started as a bold direct investment in OpenAI has bloomed into a multi-billion payoff for Michigan’s public endo...
Elon Musk says ASML has cemented its status as Europe’s top tech company, a claim that reverberates through chip equi...
Solana (sol) hits 2026 high in headlines as sentiment worsens, yet new on-chain activity and a fresh technical setup ...
Wages have begun to catch up with the cost of living, but many households still feel the squeeze as housing, grocerie...
Bitcoin teeters on a critical support with potential for an edge rally or a sharper selloff. Fresh data from on-chain...
A noted bitcoin maxi warns bip-110 as the community debates a pivotal soft fork. The warning centers on potential cen...